missing translation for 'onlineSavingsMsg'
Learn More
Learn More
FABP3/H-FABP Antibody (66E2), Novus Biologicals™
Mouse Monoclonal Antibody
Marca: Novus Biologicals NBP1-42505
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
FABP3/H-FABP Monoclonal specifically detects FABP3/H-FABP in Human, Mouse, Rat samples. It is validated for Western Blot, ELISA, Immunohistochemistry, Immunoprecipitation, Immunohistochemistry-Frozen.
Especificaciones
| FABP3/H-FABP | |
| Monoclonal | |
| 0.1 mg/mL | |
| Western Blot 1:100-1:2000, ELISA 1:100-1:2000, Immunohistochemistry 1:10-1:500, Immunoprecipitation 1:10-1:500, Immunohistochemistry-Frozen 1:10-1:500 | |
| FABP3 | |
| The antibody reacts with the H-FABP antigen. | |
| 0.2 mL | |
| Primary | |
| This monoclonal antibody (subclass IgG1) binds to human heart Fatty Acid Bindingsprotein. It shows no binding to human intestinal or liver FABP. The antibody stains heart muscle cells and striated skeletal muscle cells in immunohistochemistry. The antibody can be used to detect ischemia areas of human heart. The antibody is cross reactive with rat and mouse H-FABP. | |
| Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. | |
| IgG1 |
| Western Blot, ELISA, Immunohistochemistry, Immunoprecipitation, Immunohistochemistry (Frozen) | |
| 6600 | |
| Unconjugated | |
| FABP11, fatty acid binding protein 11, fatty acid binding protein 3, muscle and heart (mammary-derived growthinhibitor), Fatty acid-binding protein 3, Fatty acid-binding protein 3, muscle, fatty acid-binding protein, heart, Heart-type fatty acid-binding protein, H-FABPM-FABP, Mammary-derived growth inhibitor, MDGI, Muscle fatty acid-binding protein, O-FABP | |
| Mouse | |
| Protein A or G purified | |
| RUO | |
| 2170 | |
| Human, Mouse, Rat | |
| Purified |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
For Research Use Only
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido